Development and validation of a reversed phase liquid chromatographic method for separation and determination of related-substances of modafinil in bulk drugs

Talanta

Volumn 73, Issue 3, 2007, Pages 407-414

  Nageswara Rao, R ^a   Shinde, Dhananjay D ^a   Kumar Talluri, M V N ^a  

^a Analyt Chem Environ Sci Div I   (India)

Author keywords

Modafinil; Narcolepsy; Psycho stimulants; Related substances; Reversed phase HPLC

Indexed keywords

ACETONITRILE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; PH EFFECTS; PHOTODETECTORS; PHOTODIODES; SEPARATION; TRACE ANALYSIS;

MODAFINIL; NARCOLEPSY; PROCESS DEVELOPMENT; PSYCHO STIMULANTS; REVERSED PHASE HIGH-PERFORMANCE LIQUID CHROMATOGRAPHIC;

DRUG PRODUCTS;

EID: 34548434019     PISSN: 00399140     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.talanta.2007.03.057     Document Type: Article

References (21)

1. Boyd B., and Castaner J. Drugs Fut. 31 (2006) 17-21
2. Roth T., Czeisler C.A., Walsh J.K., Wesnes K.A., Williams M., Niebler G.E., and Arora S. Neuropsychopharmacology 30 (2005) S140
3. Robertson, Philmore Jr., Hellriegel, and Edward T. Clin. Pharmacokinet. 42 (2003) 123-137
4. Castaner J. Drugs Fut. 15 (1990) 130-132
5. Gorman S.H. J. Chromatogr. B 767 (2002) 269-276
6. Schwertner H.A., and Kong S.B. J. Pharm. Biomed. Anal. 37 (2005) 475-479
7. Makinney A.R., Suann C.J., and Stenhouse A.M. Rapid Commun. Mass Spectrom. 19 (2005) 1217-1220
8. Bernat P., Robles F., and Bernord Do. J. Chromatogr. B 706 (1998) 295-304
9. Moachon G., and Matinier D. J. Chromatogr. B 654 (1994) 91-96
10. Gorman S.H. J. Chromatogr. B 730 (1999) 1-7
11. Tseng Y., Uralets V., Lin C.-T., and Kuo F.-H. J. Pharm. Biomed. Anal. 39 (2005) 1042-1045
12. Cass Q.B., Kohn C.K., Calafatti S.A., and Abdul-Enein H.Y. J. Pharm. Biomed. Anal. 26 (2001) 123-130
13. Becue Th. J Chromatogr. 557 (1991) 489-494
14. Drouin J.E., and Broquaire M. J Chromatogr. 605 (1992) 19-31
15. ICH International conference on harmonization of technical requirements for registration of Pharmaceuticals for Human use, Impurities in New Drug Products, Geneva, Switzerland, 2002, Q3A (R1).
16. ICH International conference on harmonization of technical requirements for registration of Pharmaceuticals for Human use, Impurities in New Drug Products, Geneva, Switzerland, 2003, Q3B (R1).
17. Prisinzano T., Podobinski J., Tidgewell K., Luo M., and Swenson D. Tetrahedron-Asymmetr. 15 (2004) 1053-1058
18. Chetterjie N., Stables J.P., Wang H., and Alexander G.J. Neurochem. Res. 29 (2004) 1481-1486
19. Carceller E., Merlos M., Giral M., Almansa C., Batroli J., Garcia-Rafanell J., and Forn J. J. Med. Chem. 36 (1993) 2984-2997
20. L.H. Brannigan, R.J. Brinker, R.J. Kaufman, S. Metz, U.S. Patent 4,964,893 (1990).
21. L. Lafon, U.S. Patent 4,066,686 (1978).